Industry News
Mailing free tests to patients' homes boosts colon cancer screening rates in underserved populations
Feb 26, 2014
Colon cancer screening rates increased by nearly 40 percent when free stool tests were mailed to patients' homes, according to results of a pilot study published in the journal BMC Cancer.The study, funded by the National Institutes of Health (NIH), included 869 patients who received their health care from community health centers in the Portland, Ore. metropolitan area. Read More
Mailing free tests to patients' homes boosts colon cancer screening rates in underserved populations
Feb 26, 2014
Colon cancer screening rates increased by nearly 40 percent when free stool tests were mailed to patients' homes, according to results of a pilot study published in the journal BMC Cancer.The study, funded by the National Institutes of Health (NIH), included 869 patients who received their health care from community health centers in the Portland, Ore. metropolitan area. Read More
Research could help improve early diagnosis of prostate cancer
Feb 26, 2014
Prostate cancer patients could get better diagnosis and treatment for the disease in the future thanks to a successful research project at the University of Essex.Currently, is it difficult to distinguish between benign and aggressive malignant tumours, meaning some prostate cancer patients are unnecessarily "over-treated" which can lead to needless distress and anxiety. Read More
More intensive radiotherapy is better than less for localised prostate cancer
Feb 26, 2014
A radiotherapy regime involving higher doses of radiation is a better option than having lower doses for men with localised prostate cancer, the 10-year results of the largest trial of its kind have shown. Read More
NICE recommendation set to leave UK patients with newly diagnosed advanced melanoma without access to Yervoy®q (ipilimumab)
Feb 26, 2014
Bristol-Myers Squibb has expressed its disappointment that the National Institute for Health and Care Excellence (NICE) has issued draft guidance which effectively denies access to Yervoy®q (ipilimumab) for NHS patients with previously-untreated advanced (unresectable or metastatic) melanoma, not involved in clinical trials. Read More
Scientists explore promising new option for first line of attack in lymphoma
Feb 26, 2014
A study led by Manchester scientists has shown promising results for a new treatment approach in follicular lymphoma.Follicular lymphoma is a type of non-Hodgkin's lymphoma, a blood cancer, that usually develops slowly. The majority of patients are diagnosed when their disease is at an advanced stage. Read More
Novel blood screen reveals the risk of dying among healthy people
Feb 26, 2014
A new screening technology reveals a signature of mortality in blood samples. Researchers have identified four biomarkers that help to identify people at high risk of dying from any disease within the next five years.Researchers from Finland and Estonia have discovered novel biological markers that are strongly indicative of risk of dying from any disease within the near future. Read More
Blood transfusion for patients undergoing PCI associated with increased risk of in-hospital cardiac event
Feb 26, 2014
In an analysis that included more than two million patients who underwent a percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), there was considerable variation in red blood cell transfusion practices among hospitals across the U.S. Read More
Research could help improve early diagnosis of prostate cancer
Feb 26, 2014
Prostate cancer patients could get better diagnosis and treatment for the disease in the future thanks to a successful research project at the University of Essex.Currently, is it difficult to distinguish between benign and aggressive malignant tumours, meaning some prostate cancer patients are unnecessarily "over-treated" which can lead to needless distress and anxiety. Read More
More intensive radiotherapy is better than less for localised prostate cancer
Feb 26, 2014
A radiotherapy regime involving higher doses of radiation is a better option than having lower doses for men with localised prostate cancer, the 10-year results of the largest trial of its kind have shown. Read More
Previous Page Next Page